{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:16:16Z","timestamp":1792167376939,"version":"4.4.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Disturbances in lipid metabolism play a critical role in the onset and progression of diabetic kidney disease (DKD). Remnant cholesterol (RC), a marker of remnant lipoprotein metabolism, is an established cardiovascular residual risk factor. However, evidence linking RC to the risk of incident DKD is limited. This study aimed to investigate the association between RC and incident DKD and to develop a risk prediction model incorporating RC and other clinical variables in patients with type 2 diabetes (T2D).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cohort study of 2,122 patients with T2D and without baseline DKD was conducted. The association between RC and DKD risk was examined using multivariable Cox regression and restricted cubic spline (RCS) analysis. A random survival forest (RSF) algorithm was applied to identify potential predictors, followed by multicollinearity assessment. A RSF-based prediction model was developed and evaluated for discrimination, calibration, and clinical utility.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During a median follow-up of 4.22\u202fyears, 435 participants (20.5%) developed DKD. Higher RC quartiles were associated with an increased risk of DKD across all models; however, the hazard ratios for Q2 to Q4 were numerically similar, indicating the absence of a clear linear dose\u2013response pattern. RCS analysis revealed a nonlinear association between RC and DKD risk (P for nonlinearity\u202f=\u202f0.031), characterized by a steep initial increase followed by a plateau at higher RC levels. RSF identified 14 predictors (including ACR, RC) with no significant multicollinearity (all the variance inflation factors &amp;lt; 3). The model exhibited strong discrimination (3-year AUC\u202f=\u202f0.86, 5-year AUC\u202f=\u202f0.91) and calibration (3-year mean absolute error\u202f=\u202f0.011, 5-year mean absolute error\u202f=\u202f0.026), and outperformed \u201ctreat-all\u201d\/\u201ctreat-none\u201d strategies in decision curve analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>RC was independently and nonlinearly associated with DKD risk in T2D. The RSF model demonstrated good predictive performance and may assist individualized risk assessment and management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnut.2025.1697943","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T05:10:39Z","timestamp":1762837839000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Remnant cholesterol for diabetic kidney disease risk stratification in type 2 diabetes: a machine learning-based prevention tool"],"prefix":"10.3389","volume":"12","author":[{"given":"Yuehong","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huabin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic kidney disease: challenges, Progress, and possibilities","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1111\/dom.15559","article-title":"The potential for improved outcomes in the prevention and therapy of diabetic kidney disease through 'stacking' of drugs from different classes","volume":"26","author":"Bell","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.mcna.2023.03.004","article-title":"Diabetic kidney disease: an update","volume":"107","author":"Gupta","year":"2023","journal-title":"Med Clin North Am"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"S168","DOI":"10.37765\/ajmc.2021.88660","article-title":"Targeted literature review of the burden of illness in patients with chronic kidney disease and type 2 diabetes","volume":"27","author":"Fried","year":"2021","journal-title":"Am J Manag Care"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"20234","DOI":"10.1038\/s41598-023-47091-y","article-title":"Global burden and influencing factors of chronic kidney disease due to type 2 diabetes in adults aged 20-59 years, 1990-2019","volume":"13","author":"Xie","year":"2023","journal-title":"Sci Rep"},{"key":"ref6","first-page":"751","article-title":"Diabetic kidney disease: diagnosis, treatment, and prevention","volume":"99","author":"McGrath","year":"201","journal-title":"Am Fam Physician"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nefroe.2025.04.005","article-title":"Clinical practice guideline for detection and management of diabetic kidney disease: a consensus report by the Spanish Society of Nephrology","volume":"45","author":"Montero","year":"2025","journal-title":"Nefrologia (Engl Ed)"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.2337\/dci22-0027","article-title":"Diabetes Management in Chronic Kidney Disease: a consensus report by the American Diabetes Association (ADA) and kidney disease: improving global outcomes (KDIGO)","volume":"45","author":"de Boer","year":"2022","journal-title":"Diabetes Care"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1038\/s41440-024-01958-3","article-title":"Pulse pressure and kidney outcomes in diabetic kidney disease","volume":"47","author":"Hara","year":"2024","journal-title":"Hypertens Res"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1336402","DOI":"10.3389\/fendo.2024.1336402","article-title":"Lipid metabolism disorder in diabetic kidney disease","volume":"15","author":"Han","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"7413","DOI":"10.2174\/0929867328666210419132807","article-title":"The role of cholesterol homeostasis in diabetic kidney disease","volume":"28","author":"Chen","year":"2021","journal-title":"Curr Med Chem"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.coph.2020.09.004","article-title":"Lipid deposition and metaflammation in diabetic kidney disease","volume":"55","author":"Mitrofanova","year":"2020","journal-title":"Curr Opin Pharmacol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1194\/jlr.P040501","article-title":"Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy","volume":"55","author":"Herman-Edelstein","year":"2014","journal-title":"J Lipid Res"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"4268","DOI":"10.3390\/ijms24054268","article-title":"Cholesterol remnants, triglyceride-rich lipoproteins and cardiovascular risk","volume":"24","author":"Baratta","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e295","DOI":"10.3346\/jkms.2023.38.e295","article-title":"Triglyceride-rich lipoproteins and remnant cholesterol in cardiovascular disease","volume":"38","author":"Heo","year":"2023","journal-title":"J Korean Med Sci"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"zwaf345","DOI":"10.1093\/eurjpc\/zwaf345","article-title":"Remnant cholesterol, the cardiovascular-kidney-metabolic syndrome, and cardiovascular disease: lessons from CHARLS","volume":"32","author":"Miname","year":"2025","journal-title":"Eur J Prev Cardiol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-024-02556-w","article-title":"Longitudinal changes in remnant cholesterol and the risk of cardiovascular disease","volume":"24","author":"Zhang","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/jch.14384","article-title":"Association between remnant cholesterol and arterial stiffness: a secondary analysis based on a cross-sectional study","volume":"24","author":"Wang","year":"2022","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"72B","DOI":"10.1016\/s0828-282x(06)70990-4","article-title":"Arterial stiffness or endothelial dysfunction as a surrogate marker of vascular risk","volume":"22","author":"Anderson","year":"2006","journal-title":"Can J Cardiol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40885-023-00258-1","article-title":"Arterial stiffness and hypertension","volume":"29","author":"Kim","year":"2023","journal-title":"Clin Hypertens"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1053\/j.jrn.2010.05.010","article-title":"Lipotoxicity and impaired high density lipoprotein-mediated reverse cholesterol transport in chronic kidney disease","volume":"20","author":"Vaziri","year":"2010","journal-title":"J Ren Nutr"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.kint.2018.10.019","article-title":"Development and validation of a more accurate estimating equation for glomerular filtration rate in a Chinese population","volume":"95","author":"Li","year":"2019","journal-title":"Kidney Int"},{"key":"ref23","volume-title":"Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO\/IDF consultation, 2006","year":"2006"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s40618-022-01919-y","article-title":"Development and validation of a risk score for diabetic kidney disease prediction in type 2 diabetes patients: a machine learning approach","volume":"46","author":"Hosseini Sarkhosh","year":"2023","journal-title":"J Endocrinol Investig"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.2337\/dc14-S081","article-title":"Diagnosis and classification of diabetes mellitus","volume":"37","year":"2014","journal-title":"Diabetes Care"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12944-025-02632-4","article-title":"Sex-specific and metabolic subgroup heterogeneity in high-density lipoprotein cholesterol associations with diabetic kidney disease risk: a retrospective cohort study","volume":"24","author":"Wang","year":"2025","journal-title":"Lipids Health Dis"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"15362","DOI":"10.1038\/s41598-024-66548-2","article-title":"High levels of high-density lipoprotein cholesterol may increase the risk of diabetic kidney disease in patients with type 2 diabetes","volume":"14","author":"Wang","year":"2024","journal-title":"Sci Rep"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1411486","DOI":"10.3389\/fendo.2024.1411486","article-title":"The threshold effect of triglyceride glucose index on diabetic kidney disease risk in patients with type 2 diabetes: unveiling a non-linear association","volume":"15","author":"Wang","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12933-022-01667-6","article-title":"Remnant cholesterol and the risk of cardiovascular disease in type 2 diabetes: a nationwide longitudinal cohort study","volume":"21","author":"Huh","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"3258","DOI":"10.1093\/eurheartj\/ehab705","article-title":"Elevated remnant cholesterol increases the risk of peripheral artery disease, myocardial infarction, and ischaemic stroke: a cohort-based study","volume":"43","author":"Wadstr\u00f6m","year":"2022","journal-title":"Eur Heart J"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1007\/s00125-023-06016-0","article-title":"Elevated remnant cholesterol and atherosclerotic cardiovascular disease in diabetes: a population-based prospective cohort study","volume":"66","author":"Wadstr\u00f6m","year":"2023","journal-title":"Diabetologia"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"zwaf037","DOI":"10.1093\/eurjpc\/zwaf037","article-title":"The role of systemic inflammation in remnant cholesterol associated cardiovascular risk: insights from the EPIC-Norfolk study","author":"Kraaijenhof","year":"2025","journal-title":"Eur J Prev Cardiol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12967-022-03448-x","article-title":"Synergistic effect of the commonest residual risk factors, remnant cholesterol, lipoprotein(a), and inflammation, on prognosis of statin-treated patients with chronic coronary syndrome","volume":"20","author":"Liu","year":"2022","journal-title":"J Transl Med"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1286091","DOI":"10.3389\/fcvm.2024.1286091","article-title":"Long-term association of remnant cholesterol with all-cause and cardiovascular disease mortality: a nationally representative cohort study","volume":"11","author":"Chen","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.annepidem.2024.05.005","article-title":"Cumulative remnant cholesterol burden increases the risk of cardiovascular disease among young adults","volume":"94","author":"Wang","year":"2024","journal-title":"Ann Epidemiol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1373\/clinchem.2017.279463","article-title":"Remnant cholesterol and myocardial infarction in Normal weight, overweight, and obese individuals from the Copenhagen general population study","volume":"64","author":"Varbo","year":"2018","journal-title":"Clin Chem"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/s41581-024-00863-9","article-title":"The impact of population ageing on the burden of chronic kidney disease","volume":"20","author":"Chesnaye","year":"2024","journal-title":"Nat Rev Nephrol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s40620-021-01149-0","article-title":"Hypertension and cardiovascular risk factor management in a multi-ethnic cohort of adults with CKD: a cross sectional study in general practice","volume":"35","author":"Carpio","year":"2022","journal-title":"J Nephrol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12944-023-01995-w","article-title":"Association of remnant cholesterol with decreased kidney function or albuminuria: a population-based study in the U.S","volume":"23","author":"He","year":"2024","journal-title":"Lipids Health Dis"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1159\/000543037","article-title":"Association of Cumulative Remnant Cholesterol with kidney function decline in Chinese population: a prospective cohort study","volume":"11","author":"Liu","year":"2025","journal-title":"Kidney Dis (Basel)"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/nrneph.2009.184","article-title":"An update on the lipid nephrotoxicity hypothesis","volume":"5","author":"Ruan","year":"2009","journal-title":"Nat Rev Nephrol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.2337\/db05-0603","article-title":"Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes","volume":"55","author":"Proctor","year":"2006","journal-title":"Diabetes"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1161\/CIRCULATIONAHA.113.003008","article-title":"Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation","volume":"128","author":"Varbo","year":"2013","journal-title":"Circulation"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13098-025-01617-8","article-title":"The prognostic value of remnant cholesterol to adverse renal outcomes in patients with type 2 diabetes","volume":"17","author":"Yu","year":"2025","journal-title":"Diabetol Metab Syndr"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2025.1697943\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T05:10:42Z","timestamp":1762837842000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2025.1697943\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":44,"alternative-id":["10.3389\/fnut.2025.1697943"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2025.1697943","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"article-number":"1697943"}}